3266 Participants Needed

Radial vs. Femoral Access for Cardiac Catheterization Complications

(REBIRTH Trial)

Recruiting at 5 trial locations
BR
OM
Overseen ByOlga Mastrodemos
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Minneapolis Heart Institute Foundation
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests two methods for cardiac catheterization, a procedure to assess heart health. It compares the radial approach, which uses the wrist, with the femoral approach, which uses the groin. The femoral approach further divides into using either an 18-gauge needle or a 21-gauge needle. The trial aims to determine which method results in fewer complications for individuals without a specific type of heart attack. Participants should experience heart-related symptoms and require a heart procedure but must not have had a recent severe heart attack. As an unphased trial, this study allows participants to contribute to important research that could enhance cardiac care techniques.

Will I have to stop taking my current medications?

The trial protocol does not specify if you need to stop taking your current medications. However, if you are taking oral factor Xa or IIa inhibitors, you should not have taken them within 24 hours before the procedure.

What is the safety track record for these treatments?

Research shows that using the wrist (radial access) for heart procedures is generally safe. The most common issue is a 5% chance of artery blockage in the wrist, which is usually not serious. Serious problems, such as a tear in the artery or a painful condition from pressure buildup, are rare. The wrist method also results in less bleeding compared to the groin (femoral access).

For the groin method, even with the latest techniques, sources do not highlight specific safety concerns. However, advanced tools like ultrasound and special devices can enhance safety.

Overall, both wrist and groin methods have been successfully used in many patients. Each has its own risks, but they are generally well-tolerated.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it compares two different techniques for cardiac catheterization—radial access and femoral access. Radial access stands out due to its use of ultrasound guidance and a micropuncture needle or a catheter-over-needle system, which can potentially lead to fewer complications and quicker recovery times compared to traditional femoral access. On the other hand, the femoral access technique is being evaluated with state-of-the-art enhancements like ultrasound and fluoroscopic guidance, immediate angiography after arterial access, and the use of a vascular closure device, all of which aim to improve safety and outcomes. By comparing these advanced techniques, the study seeks to determine which approach minimizes complications and enhances patient recovery.

What evidence suggests that this trial's access methods could be effective for cardiac catheterization?

Research has shown that using the wrist (radial access) for cardiac catheterization is highly effective, achieving a success rate of over 90% for diagnostic procedures. In this trial, participants will undergo either radial access or femoral access for their procedure. Studies have found that radial access significantly reduces bleeding compared to groin (femoral) access. Regarding safety, the risk of death within 30 days is similar for both methods. Both approaches are effective and offer distinct benefits, but wrist access might slightly lower the risk of certain complications.34678

Who Is on the Research Team?

EB

Emmanouil Brilakis, MD, PhD

Principal Investigator

Minneapolis Heart Institute Foundation

Are You a Good Fit for This Trial?

Adults over 18 eligible for cardiac catheterization via both radial and femoral access, who consent to participate. Suitable for those needing diagnostic angiography or urgent/elective PCI, but not for patients with recent oral anticoagulant use, peripheral arterial disease affecting access sites, limited life expectancy, certain heart conditions or procedures within the next month.

Inclusion Criteria

Has provided informed consent and agrees to participate
I am scheduled for a heart artery exam due to chest pain, possibly with treatment.
I can have a heart catheterization through my wrist or groin.

Exclusion Criteria

I took blood thinners less than 24 hours before the procedure.
I have a dialysis access point in my arm that can be used for a heart procedure.
Coexisting conditions that limit life expectancy to less than 30 days
See 10 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo cardiac catheterization using either radial or state-of-the-art femoral access

During procedure
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the procedure, including evaluations of myocardial infarction and procedural success

4 weeks
Evaluations up to 30 days

What Are the Treatments Tested in This Trial?

Interventions

  • Radial Access
  • State-of-the-art femoral access with 18 gauge needle
  • State-of-the-art femoral access with 21 gauge needle
Trial Overview This phase IV trial compares two methods of accessing the heart during catheterization: through the wrist (radial access) and upper thigh (femoral access). Participants are randomly assigned to one method; those in the femoral group are further randomized to receive either a smaller (21 gauge) or larger (18 gauge) needle.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: State-of-the-art femoral accessActive Control2 Interventions
Group II: Radial accessActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Minneapolis Heart Institute Foundation

Lead Sponsor

Trials
32
Recruited
15,700+

Published Research Related to This Trial

In a study of 56 patients on uninterrupted warfarin therapy, radial access for cardiac catheterization was found to be as effective as femoral access, with procedural success achieved in all femoral patients and only one crossover in the radial group.
Radial access significantly reduced access-site complications during percutaneous coronary intervention (PCI), with 37.5% of femoral patients experiencing complications compared to none in the radial group, highlighting its safety advantage.
Radial versus femoral access for orally anticoagulated patients.Ziakas, AG., Koskinas, KC., Gavrilidis, S., et al.[2014]
In a study of 499 patients undergoing transradial coronary procedures, the rate of radial artery occlusion at 90 days was low at 5%, with no significant difference between the new RY Stop device and the standard TR Band.
While both devices showed similar levels of discomfort and low rates of vascular complications, the RY Stop device was associated with a higher incidence of bleeding (12% vs. 3% for TR Band), indicating a potential safety concern.
Is radial artery occlusion and local vascular complications following transradial coronary procedures affected by the type of haemostasis device used? A non-inferiority Randomized Controlled Trial (RadCom trial).Due-Tønnessen, N., Egeland, CH., Meyerdierks, OJ., et al.[2022]
In a study of 58,862 PCI procedures, radial access resulted in significantly fewer major bleeding events (0.9%) compared to femoral access (2.2%), indicating a potential safety advantage for radial access.
However, radial access was associated with higher radiation exposure and longer fluoroscopy times, suggesting that while it may reduce bleeding risks, femoral access with bivalirudin could be the safest option overall for PCI procedures.
Analysis of safety outcomes for radial versus femoral access for percutaneous coronary intervention from a large clinical registry.Dobies, DR., Barber, KR., Cohoon, AL.[2021]

Citations

Effectiveness and safety of transradial artery access for ...The success rate for diagnostic angiography through the radial artery is well over 90%, and it is rare to need to switch to a femoral approach. To date, there ...
Procedural Outcomes With Femoral, Radial, Distal ...Radial access significantly reduced bleeding complications when compared with femoral access and thus supports the guideline recommendation of a ...
Efficacy and Safety of Distal Radial Artery Access versus ...Eight studies reported a success rate of the procedure having 4,352 patients (2,170 DRA vs. 2,182 PRA). The analysis showed comparable results (RR 0.98, 95% CI: ...
Outcomes of distal versus conventional transradial access ...The access success rate was 94.3%, which is comparable with the proximal radial approach. •. The distal approach significantly reduced the rate ...
Safety and Efficacy of Femoral Access vs Radial Access in ...The primary outcome, 30-day all-cause mortality, occurred in 17 patients (1.5%) assigned to radial access and in 15 patients (1.3%) assigned to ...
Cardiac Catheterization Risks and Complications - NCBI - NIHThe most frequent complication after transradial access is about a 5% risk of radial artery occlusion. This is a clinically insignificant complication if the ...
Transradial Artery Access Complications | CirculationMajor intra- and postprocedural complications such as radial artery perforation and compartment syndrome are rare following TRA. Their ...
Managing Complications of Transradial CatheterizationThese complications include arterial injury, spasm, occlusion, perforation, hematoma, and pseudoaneurysm.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security